Nurix Therapeutics Appoints Paula G. O’Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer
Position
Chief Technical Officer
Company
Nurix Therapeutics
Description
Nurix Therapeutics, Inc. announced the appointments of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa, Ph.D., as chief technical officer of Nurix
Quick answer
Nurix Therapeutics Appoints Paula G. O’Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer (May 28, 2024). Nurix Therapeutics is based in Brisbane, California, United States.
- Who is the new Chief Technical Officer at Nurix Therapeutics?
- Nurix Therapeutics named Pasit Phiasivongsa Chief Technical Officer, announced May 28, 2024.
- What did Nurix Therapeutics announce on May 28, 2024?
- Nurix Therapeutics, Inc. announced the appointments of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa, Ph.D., as chief technical officer of Nurix
- What does Nurix Therapeutics do?
- Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases.
- Where is Nurix Therapeutics based?
- Nurix Therapeutics is based in Brisbane, California, United States.
- Which similar companies made leadership changes around the same time?
- Tarsier Pharma (May 28, 2024), Alkeus Pharmaceuticals (May 29, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Oragenics (May 22, 2024) also announced leadership changes within 45 days of Nurix Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsier Pharma Appoints Emilee Fulcher as Vice President of Clinical Affairs (May 28, 2024)
- Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer (May 29, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial (May 22, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
Who to call at Nurix Therapeutics, and when
A new leader at Nurix Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nurix Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nurix Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nurix Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nurix Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nurix Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.